The medium used for slice incubation and superfusion, BBS, contained (in millimolar) NaCl 126, KCl 2.5, NaH2PO4 1.25, NaHCO3 26, CaCl2 2, MgCl2 1, and glucose 25, bubbled with 95% O2–5% CO2. The slicing medium, GCS, contained (in millimolar) KGluconate 130, KCl 15, EGTA 2, Hepes 20, glucose 25, and D-AP5 0.05 (to block NMDA receptors), pH-adjusted to 7.4 with NaOH. This high-potassium/EGTA (intracellular-mimicking) medium was used solely during slicing at 4 °C (42, 44) to enable better protection despite unavoidable mechanical membrane damage produced by slicing. Immediately following slicing, slices were immerged in a recovery medium (MCS) for a transition from the high-K+, low-Ca2+ GCS to the low-K+, high-Ca2+ BBS. MCS contained (in millimolar) d-mannitol 225, KCl 2.5, NaH2PO4 1.25, NaHCO3 25, and glucose 25. All superfusion solution contained 10 µM GABAzine. For patch-clamp experiments, normal intracellular (pipette) solution contained (in millimolar) KMeSO4 145, NaCl 6, Hepes 10, K2.5EGTA 0.5, MgCl2 1, MgATP 4, and Na2GTP 0.5, pH-adjusted to 7.35 with KOH. This medium was stored at −80 °C. Alexa Fluor 594 hydrazide was added at 15 µM just before patching.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.